FTC Sues WPATH Over 2022 Minors' Care Guidelines as Group Denies Deception Claims
Updated
Updated · Fox News · Jun 21
FTC Sues WPATH Over 2022 Minors' Care Guidelines as Group Denies Deception Claims
3 articles · Updated · Fox News · Jun 21
Summary
A Texas federal complaint by the FTC and four Republican-led states accuses WPATH of misleading parents and doctors by presenting youth gender-transition treatments as evidence-based despite uncertain benefits and serious risks.
The suit cites WPATH leaders' own statements, including a 2023 memo acknowledging major research gaps, and alleges the group dropped 2022 age minimums for some procedures without scientific justification.
Federal regulators also allege guideline authors had financial or professional conflicts and that WPATH promoted interventions as "lifesaving" without sufficient evidence they reduce suicide risk.
WPATH rejected the case as politically motivated and legally flawed, saying its standards reflect scientific norms, expert consensus and patient-centered values.
Because WPATH's standards have shaped provider practices, insurance coverage and other medical guidelines, the case could reverberate across U.S. pediatric transgender care.
As Europe restricts youth gender treatments, will a landmark FTC lawsuit force a medical reckoning in the United States?
Top medical standards are now being sued for deception. How can families navigate life-altering youth healthcare decisions?
With medical guidelines under fire, what does science reveal about long-term outcomes for youth who medically transition?
FTC Sues WPATH: The 2026 Legal Battle Over Gender-Affirming Care for Minors and Its National Impact
Overview
In June 2026, the U.S. Federal Trade Commission (FTC), along with several states, filed a lawsuit against the World Professional Association for Transgender Health (WPATH), alleging that WPATH made deceptive and unsubstantiated claims about the necessity, effectiveness, and safety of gender-affirming care for minors. The FTC argues that WPATH’s guidelines lack strong scientific evidence and may mislead families, with some clinicians reportedly using coercive statements when advising parents. WPATH denies these allegations, calling the lawsuit baseless and politically motivated. This case highlights growing scrutiny over medical guidelines and the debate about informed consent in pediatric gender-affirming care.